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Abstract
Objectives Recent studies have proposed additional
multidetector-row CT (MDCT) for prosthetic heart valve
(PHV) dysfunction. References to discriminate physiological
from pathological conditions early after implantation are lack-
ing. We present baseline MDCT findings of PHVs 6 weeks
post implantation.
Methods Patients were prospectively enrolled and TTEwas per-
formed according to clinical guidelines. 256-MDCTimageswere
systematically assessed for leaflet excursions, image quality,
valve-related artefacts, and pathological and additional findings.
Results Forty-six patients were included comprising 33mechan-
ical and 16 biological PHVs. Overall, MDCT image quality was
good and relevant regions remained reliably assessable despite
mild-moderate PHV-artefacts. MDCT detected three unexpected
valve-related pathology cases: (1) prominent subprosthetic tissue,
(2) pseudoaneurysm and (3) extensive pseudoaneurysms and
valve dehiscence. The latter patient required valve surgery to
be redone. TTE only showed trace periprosthetic regurgitation,
and no abnormalities in the other cases. Additional findingswere:
tilted aortic PHV position (n=3), pericardial haematoma (n=3)
and pericardial effusion (n=3). Periaortic induration was present
in 33/40 (83 %) aortic valve patients.
Conclusions MDCT allowed evaluation of relevant PHV re-
gions in all valves, revealed baseline postsurgical findings
and, despite normal TTE findings, detected three cases of
unexpected, clinically relevant pathology.
Key Points
• Postoperative MDCT presents baseline morphology relevant
for prosthetic valve follow-up.
• 83 % of patients show periaortic induration 6 weeks after
aortic valve replacement.
• MDCT detected three cases of clinically relevant pathology
not found with TTE.
• Valve dehiscence detection by MDCT required redo valve
surgery in one patient.
• MDCT is a suitable and complementary imaging tool for
follow-up purposes.
Keywords Multidetector-row computed tomography . Heart
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Abbreviations
BMI Body mass index
BPM Beats per minute
EOA Effective orifice area
LVOT Left ventricular outflow tract
MDCT Multidetector-row computed tomography
PHV Prosthetic heart valve
RCA Right coronary artery
TTE Transthoracic echocardiography
VTI Velocity time integral
Introduction
Current cardiology guidelines recommend transthoracic echo-
cardiography (TTE) 6–12 weeks after valve replacement sur-
gery as a baseline for adequate patient follow-up [1, 2]. For
mechanical valves, TTE is only repeated in case of suspected
dysfunction, whereas for biological valves annual TTE assess-
ment should be planned after the first 5 years [1]. As addition-
al modalities for the evaluation of prosthetic valve dysfunc-
tion, transoesophageal echocardiography and cinefluoroscopy
are advised. However, these imaging modalities often cannot
identify the cause of obstruction or the extent of endocarditis-
related pathology [3, 4]. Several preliminary studies have
shown the incremental value of ECG-gated multidetector-
row computed tomography (MDCT) for the evaluation of pa-
tients with prosthetic heart valves (PHV) [4–8]. Recently,
MDCT was added to the American College of Cardiology
and European Society of Cardiology guidelines as a potential
additional imaging modality for patients with suspected PHV
thrombus [1, 2], pannus [1] or endocarditis [2]. Before MDCT
can be fully implemented in daily clinical practice, it is essen-
tial to be able to discriminate normal from pathological con-
ditions. As proposed with TTE imaging, follow-up results
should be compared to the acquired baseline references [1].
Currently, normal references for MDCT findings early after
PHV implantation are lacking. The purpose of this study was
to evaluate the baseline MDCT imaging characteristics




A prospective study was conducted to acquire standardized
TTE and MDCT images 6 weeks after PHV implantation.
Patients were consecutively enrolled between June 2010 and
September 2013 after surgical aortic or mitral heart valve re-
placement in the University Medical Center Utrecht and Ac-
ademic Medical Center Amsterdam, The Netherlands. The
inclusion criterion was successful implantation of one of the
common surgical PHV types of the participating institutions:
St. Jude Medical, Sorin Carbomedics, ON-X, Sorin Bicarbon,
Carpentier-Edwards Perimount or Sorin Mitroflow. Exclusion
criteria consisted of (1) known allergy to contrast media, (2)
other contraindications for contrast use such as an estimated
glomerular filtration rate <60 ml/min/1.73 m2, (3) contraindi-
cation for MDCT imaging, (4) possible pregnancy and (5)
refusal to be informed about additional MDCT findings.
This study was approved by the Institutional Review Board
and all patients gave written informed consent before inclusion.
Transthoracic echocardiography (TTE) imaging
and analysis
TTE was performed on the principal investigation site
(Utrecht) 6 weeks after implantation according to routine
follow-up guidelines and by using standard clinical echocar-
diographic equipment. Images were evaluated by one inde-
pendent observer (MM; cardiologist) with 5 years’ experience
in cardiac imaging. A second observer (SC; imaging cardiol-
ogist) with 8 years’ experience in PHV imaging evaluated all
cases of abnormalities and pathological findings for a consen-
sus score. Both observers were blinded for MDCT results.
PHV assessment was conducted according to the guidelines
[1, 9] and included measurements of the mean and peak
transprosthetic gradients, velocity time integrals (VTI), calcu-
lation of effective orifice area (EOA) and evaluation of regur-
gitation. The VTI was measured through the left ventricular
outflow tract (LVOT) and across the PHV (aortic or mitral).
The EOAwas calculated using the LVOT diameter and Dopp-
ler continuity equation for all PHVs [10, 11], as the pressure
half-time method is not preferred in mitral PHVs [9]. Avail-
able guidelines specified per PHVmanufacturer and PHV size
were used as reference [9]. Periprosthetic regurgitation was
scored on a visual scale as none, trace, mild, moderate or
severe. Prosthetic regurgitation was scored as normal for
PHV, trace, mild, moderate or severe. Additional
(pathological) findings were reported. Left ventricular func-
tion was measured on available 3D full volume dataset, or 2D
images by the Simpson biplane method and scored as normal
(>55 %), mild dysfunction (45–55 %), moderate dysfunction
(30–45 %) or severe dysfunction (<30 %). If measurements
were not possible, the left ventricular function was estimated.
MDCT imaging
MDCT images were acquired on the same day as TTE imag-
ing using a 256-slice MDCT system (iCT, Philips Healthcare,
Best, The Netherlands). The acquisition protocol consisted of
a non-enhanced prospectively ECG-triggered acquisition of
the PHV region with the following parameters: collimation
128×0.625 mm, gantry rotation time 270 ms, tube voltage
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120 kV and tube current-time product 30 mAs. For contrast-
enhanced imaging a triphasic injection protocol was applied
using iodinated contrast agent (Ultravist 300 mg/ml; Bayer
Healthcare Pharmaceutical Inc.). First, the contrast agent
was administered followed by a mixture of contrast agent
and saline in 30/70 ratio, respectively and a saline flush at last
(mean flow rate 6-6.7 cc/s). Flow and volume injection were
weight dependent and a threshold of 100 Hounsfield units in
the descending aorta was used for acquisition. No beta
blockers were administered for heart rate control. The
contrast-enhanced retrospectively ECG-gated acquisition of
the cardiac region was performed according to the following
protocol: collimation 128×0.625 mm, gantry rotation time
270 or 330 ms, pitch 0.16 or 0.18, tube voltage 120 kV and
tube current-time product 600 or 700 mAs. The rotation time
and pitch were dependent on the heart rate (<62, 62-72 or >72
beats per minute; bpm) and the tube current-time product on
the patients’ body weight (65-80 or >80 kg). Images were
reconstructed at each 10 % phase of the RR-interval with a
0.45 increment and 0.9 mm slice thickness. The dose-length
product (mGy*cm) extracted from the MDCT dose reports
and the conversion factor for adult chest MDCTexaminations
(0.0145 mSv/mGy*cm) were multiplied to acquire the effec-
tive per patient radiation dose (mSv) [12].
Multidetector-row computed tomography (MDCT)
analysis
Images were analysed on a dedicated workstation (Extended
Brilliance Workstation v4.5, Philips Healthcare, Best,
The Netherlands). For each PHV, the best systolic and diastolic
imaging phasewas selected. Both phases were used to assess the
image quality, PHV-related artefacts and leaflet motion. Image
quality and PHV-related artefacts were assessed for five PHV-
related regions as published previously [13, 14]: the
supraprosthetic, periprosthetic, subprosthetic, prosthetic and
valve leaflet region. Image quality was scored on a 4-point scale
as follows: (1) non-diagnostic with no discernible detail widely
beyond the prosthesis, (2) moderate with no details <5 mm of
the prosthesis, (3) goodwith some structure details <5mmof the
prosthesis and (4) excellent visualization with perfect structure
details. PHV-related artefacts were scored as: (1) virtually none,
(2) mild artefacts <5 mm beyond the prosthesis, (3) moderate
artefacts >5 mm beyond the prosthesis and (4) severe artefacts
beyond the border of the valve chamber. For mechanical PHVs,
the leaflet opening and closing angles were measured [15] and
cine images reconstructed for evaluation of symmetrical leaflet
excursions. Pericardial effusion was evaluated and scored as
physiological, mild or moderate. The fat tissue surrounding the
aorta and aortic PHVs was assessed and tissue induration was
reported when present. Polytetrafluoroethylene felt pledgets im-
planted during valve surgery were reported when visible. All
PHVs were systematically evaluated and scored for unexpected
pathology such as thrombus, pannus, vegetations, mycotic an-
eurysms, biological leaflet thickening, pseudoaneurysms, PHV
dehiscence and PHV angulation in relation to the LVOT axis.
For all patients possible additional findings were reported as
well. One observer (DS) with 2 years’ experience in PHV im-
aging performed all MDCT measurements independently. Im-
age quality, artefacts and pathology were assessed by a second
observer (RB) with 7 years’ experience additionally for a con-
sensus score. Both observers were blinded for TTE results.
Statistical analysis
For analysis of the acquired data descriptive statistics were
applied using SPSS version 20.0 for Windows. As measures
of central tendency and dispersion, the mean±standard devi-
ation (SD) or median [interquartile range; IQR] are provided,
based on the data distribution. For summary statistics the num-
ber and percentage are provided.
Results
A total of 68 patients were consecutively included after valve
surgery. Of these, 16 patients decided upon study withdrawal
at 6 weeks, one patient died, one patient showed an impaired
renal function, one patient underwent MDCT for clinical rea-
sons and three patients were excluded because of imaging
protocol violation. Hence, 46 patients with 49 valves were
included. Patient characteristics are presented in Table 1. Me-
dian time between valve replacement surgery and TTE/
MDCT imaging was 44 days [IQR 41–52]. TTE and MDCT
examinations were performed on the same day in 45 patients
and with an interval of 2 days in one patient.
TTE
The mean heart rate during TTE examinations was 74±
16 bpm. Six of 46 patients had atrial fibrillation during exam-
ination. Left ventricular ejection fraction was normal in 30
patients, showed mild dysfunction in seven patients, moderate
dysfunction in six patients and severe dysfunction in three
patients. Mean EOA was 2.00±0.64 for aortic and 2.05±
0.41 for mitral PHVs. An overview of all TTE results on
PHV assessment is presented in Table 2. One patient with a
Carbomedics 27-mm PHV showedmild to moderate prosthet-
ic regurgitation but this was considered clinically insignifi-
cant. Hence, TTE results on prosthetic and periprosthetic re-
gurgitation did not show any pathological findings requiring
short-term interventions. Pericardial effusion was not present
or scored as physiological (<2 mm) in 42 patients on TTE
imaging at 6 weeks. One patient showed pericardial effusion
of 7 mm and three patients had greater pericardial effusion
Eur Radiol (2016) 26:997–1006 999
(12, 12 and 13 mm). An example of good quality TTE images
for a biological and mechanical PHV is presented in Fig. 1.
MDCT
The mean effective radiation dose was 11.3±1.1 mSv. Heart
rate during MDCT examinations was known in 38/46 patients
and was 72±16 bpm (mean±SD). Two patients showed ar-
rhythmias during MDCT acquisition, 36 patients had a normal
sinus rhythm. The optimal MDCT reconstructions were 30–
40 % systolic and 75–80–90 % diastolic phases (Electronic
Supplementary Material Table S1). Results on image quality
and artefacts are presented in Electronic Supplementary
Material Tables S2 and S3, classified by manufacturer and
anatomical region. For aortic valves in general, moderate arte-
facts and image quality were found for the periprosthetic re-
gion, and good image quality with only mild artefacts for the
other regions. For mitral valves, mild to moderate artefacts with
moderate to good image quality were present for the
periprosthetic, subprosthetic and prosthetic regions and good
image quality with mild artefacts for the supraprosthetic re-
gion. All mechanical valves showed good to excellent leaflet
image quality whereas the biological Mitroflow and
Perimount showed moderate and non-diagnostic leaflet image
quality, respectively (Fig. 1). Mechanical leaflet excursions
are presented in Table 3. The differences in angles between
both leaflets of one PHV were assessed and a maximal me-
dian difference of 4° for opening and 7° for closing angles
was found. Leaflet motion as assessed on cine images
showed symmetrical leaflet excursions in all (n=33) mechan-
ical PHVs.
Additional findings
MDCT detected moderate pericardial effusion in three pa-
tients, the same patients as those detected by TTE. MDCT
also showed a slight aortic PHV angulation in three patients.
Prominent haematoma at periaortic and/or pericardial position




Male, n (%) 37 (80 %)
Prior myocardial infarction 1 (2 %)
Prior cardiac surgery 8 (17 %)
BMI, mean±SD 27.3±4.8
BSA 1.98±0.22
Concomitant bypass surgery 10 (22 %)
Concomitant other procedure 15 (33 %)
Medication at discharge
Vitamin K antagonists 43 (94 %)
Antiplatelet drugs 16 (35 %)
Rate control drugs 39 (85 %)
PHV type implanted, n (%) Aortic, N=40 (82 %) Mitral, N=9 (18 %)
St. Jude Medical 8 (20 %) 4 (44 %)
Carbomedics 11 (28 %) 1 (11 %)
ON-X 3 (8 %) 2 (22 %)
Sorin Bicarbon 3 (8 %) 1 (11 %)
Perimount (biological) 11 (28 %) 1 (11 %)
Mitroflow (biological) 4 (10 %) -
PHV size
21 mm 2 (5 %) -
23 mm 18 (45 %) -
25 mm 13 (33 %) 2 (22 %)
27 mm 6 (15 %) 2 (22 %)
29 mm 1 (3 %) 1 (11 %)
31 mm - 3 (33 %)
33 mm - 1 (11 %)
BMI body mass index, BSA body surface area, PHV prosthetic heart valve, SD standard deviation
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was present in three patients (Fig. 2). Most importantly, the
periaortic fat tissue in patients after aortic valve replacement
showed induration in 33 patients. Of those, two patients
showed severe periaortic fat tissue induration (Fig. 2f).
Fig. 1 Example of biological and
mechanical prosthetic heart valve
imaging. Transthoracic
echocardiography images (a, c)
and multidetector-row computed
tomography images (b, d) of a
normal functioning Perimount
25-mm biological valve (a, b) and
a normal functioning
Carbomedics 23-mm mechanical
heart valve (c, d) in the aortic
position
Table 2 Transthoracic echocardiography results: patient characteristics 6 weeks after prosthetic valve implantation
TTE Aortic PHV=40 Mitral PHV=9
Effective orifice area*, mean±SD 2.00±0.64 2.05±0.41
Mean transprosthetic gradient, median [IQR] 9.4 [6.0–12.7] 5.8 [4.1–6.6]
Peak transprosthetic gradient 17.5 [12.2–27.1] 14.7 [7.7–17.4]
Periprosthetic regurgitation, n (%)
None 38 (95 %) 9 (100 %)
Trace 1 (3 %) -




Normal for PHV 38 (95 %) 9 (100 %)
Trace 1 (3 %) -
Mild - -
Moderate 1 (3 %) -
Severe - -
PHV prosthetic heart valve, TTE transthoracic echocardiography
* Based on the Doppler continuity equation and measured left ventricular outflow tract diameter
† Graded according to clinical routine based on mean and peak gradients, effective orifice area, cardiac output and available PHV type and size specific
reference values
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Pathology
MDCT found PHV-related pathology in three patients. First,
MDCT detected prominent subprosthetic tissue in one patient
with an aortic biological Perimount 23 mm (Fig. 3). Differen-
tial diagnosis was a retracted annulus, native valve remnant or
small thrombus. Second, a pseudoaneurysm (approximately
22×9×13 mm) was found on the supraprosthetic site near
the former left and non-coronary cusp in a patient with an
aortic biological Perimount 25 mm, requiring follow-up
(Fig. 4). In addition, a malignant coronary anomaly was re-
vealed in this patient showing the right coronary artery (RCA)
deriving from the left ostium and coursing between the aorta
and pulmonary trunk. Since MDCT showed RCA tapering,
clinical evaluation and cardiac stress testing was required.
Third, MDCT detected extended pseudonaneurysm formation
and valve dehiscence in a patient with an aortic mechanical St.
Jude 23 mm (Fig. 5). This patient eventually had to undergo
redo surgery. In this patient, TTE only detected a trace of
periprosthetic regurgitation stated as clinically not relevant.
Fig. 2 Additional findings with multidetector-row computed
tomography. (a) Example of a patient with a slightly tilted position of
an aortic Perimount prosthesis. (b) Prominent pleural haematoma (35
Hounsfield Units; arrowhead) and pericardial haematoma (31
Hounsfield Units; arrow) in a patient 6 weeks after implantation of the
aortic St. Jude valve. (c) Prominent pericardial effusion (stars) at 6 weeks’
follow-up after biological Perimount implantation in the aortic position.
(d-f) Multidector-row computed tomography (MDCT) images of the
proximal ascending aorta in the short axis view in a patient without
evident induration of the periaortic fat tissue (d), with moderate
induration (e; empty arrowheads) and with severe induration of the
periaortic tissue (f; empty arrowheads)
Table 3 Multidetector-row computed tomography mechanical valve leaflet angles as measured and compared to manufacturers’ values
Opening angles (°)* Closing angles (°)*
Aortic Δ leaflets† Mitral Δ leaflets MFR Aortic Δ leaflets† Mitral Δ leaflets MFR
St. Jude, 19–25 mm 84 (82–88) 4 (1–6) n/a n/a 85 30 (26–34) 5 (3–7) n/a n/a 30
St. Jude, 27–31 mm 85 (83–87) 2 (1–4) 83 (80–85) 3 (1–5) 85 23 (22–27) 3 (0–5) 23 (22–27) 2 (0–5) 25
Carbomedics 80 (72–82) 2 (0–3) 73 (72–74) 2 (–) 78 24 (20–28) 3 (0–7) 24 (22–27) 5 (–) 25
Sorin Bicarbon 79 (78–80) 1 (1) 78 (77–78) 1 (–) 80 21 (19–22) 1 (1–3) 20 (19–20) 1 (–) 20
On-X 79 (76–84) 4 (1–6) 76 (75–80) 4 (2–6) 90 40 (39–42) 1 (0–2) 40 (39–41) 1 (1) 40
MFR manufacturer, n/a not available
* Median and total range (minimum–maximum) in degrees provided
† Median difference between the both leaflet angles of a specific prosthetic heart valve in each single patient
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After the MDCT-based diagnosis, the patient underwent addi-
tional multimodality imaging [16]. Table 4 provides an over-
view of all PHV morphology as detected by MDCT.
Discussion
The current study demonstrates that MDCT is a feasible and
valuable tool for PHV patient follow-up. We presented the
baseline MDCT imaging characteristics and PHV morpholo-
gy shortly after valve replacement surgery. The major finding
was the detection of three cases of unexpected but clinically
important valve-related pathology that were missed by routine
TTE imaging. Furthermore, MDCT showed that in the early
postoperative stage 83 % of aortic valve patients present in-
duration of the periaortic fat tissue, which can be considered a
normal finding at this stage.
In this study, the presence of moderate valve-related arte-
facts did not hamper the image quality. Regions that are most
relevant for clinical evaluation of PHV-related pathology such
as the periprosthetic and subprosthetic region remained visible
and reliably assessable despite the presence of artefacts. In
patients with a high body mass index (BMI), TTE imaging
may be challenging and result in poor image quality whereas
MDCT imaging may be hampered by higher image noise
levels. In this cohort though, mean BMI was 27.3 but did
not preclude reliable MDCT assessment. Hence, MDCT im-
aging might be less affected by increased BMI than TTE
imaging.
Leaflet motion can be evaluated with MDCT as demon-
strated previously [15]. The maximal difference between the
measured angles and manufacturer values was 15° for the ON-
X valve but only 6° for all other mechanical valves. Although
the leaflets of the ON-X valve are designed to open to 90°, our
study demonstrated a more reduced opening angle for this
valve type in all patients, without any signs of dysfunction
or elevated transprosthetic gradients. This phenomenon has
previously also been found using fluoroscopy in patients with
aortic On-X valves [17] and in phantom setting in mitral ON-
X valves [18]. For biological leaflets, Chenot et al. [5] previ-
ously measured leaflet angles in a variety of biological valve
types. In our cohort, the leaflets of the biological Perimount
Fig. 4 Detection of a pseudoaneurysm. Multidetector-row computed
tomography (MDCT) detected a pseudoaneurysm on the
supraprosthetic site near the former left and non-coronary cusp in a 74-
year-old male patient 6 weeks after aortic Perimount 25-mm
implantation. The pseudoaneurysm (arrowheads) of approximately 22×
9×13 mm is presented on the in-plane (a) and the perpendicular plane
MDCT views (b, c). No pathology or periprosthetic regurgitation was
found with transthoracic echocardiography. LCA left coronary artery
Fig. 3 Unexpected pathology detected with MDCT imaging.
Multidector-row computed tomography (MDCT) images of a 69-year-
old male patient 6 weeks after aortic Perimount 23-mm implantation (a-
c). Note the presence of the subprosthetic hypodense tissue (arrowhead)
on both the in-plane (b) and the perpendicular plane image (c).
Differential diagnosis: retracted annulus, native valve remnant or small
thrombus. Transthoracic echocardiography did not detect any
abnormalities in this patient. The stars in the image indicate the
presence of polytetrafluoroethylene felt pledgets
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valves were not assessable. Whereas during follow-up the
biological leaflets may thicken and become more visible, in
normal settings early after implantation these leaflets were too
thin for MDCT assessment. Nevertheless, MDCT allowed as-
sessment of both aortic and mitral valve leaflet angles while
conventional fluoroscopy has shown significant problems in
positioning the beam perpendicular to the valve leaflets in
certain anatomical valve orientations [17, 19]. Another re-
markable MDCT finding was the induration of the periaortic
fat tissue in 83 % of normal follow-up patients with aortic
valves. In patients suspected of PHVendocarditis, the appear-
ance of this area is of paramount importance for diagnosis.
Apparently, 6 weeks post uncomplicated aortic valve surgery,
the periaortic fat tissue is still disturbed in the majority of
patients and can be considered a normal baseline finding.
However, it is not known how long this periaortic induration
persists. In case of early postoperative endocarditis suspicion
it might be difficult to distinguish a physiological state from
pathological conditions based solely on the fat tissue’s MDCT
appearance. Further studies are needed to establish the dura-
tion of periaortic induration. In future setting, additional 18 F-
fluorodeoxyglucose positron emission tomography might
possibly aid in the diagnostic work-up of endocarditis patients
by showing increased metabolic uptake values [16].
Although TTE remains important for providing haemody-
namic information, MDCT demonstrated several findings that
were not detected by TTE. For example, MDCT found a tilted
position of three aortic PHVs, which has been related to an
increased transprosthetic gradient [4]. In patients with
suspected PHV dysfunction, MDCT may aid in diagnostic
work-up by detecting a tilted position as the cause of obstruc-
tion. Furthermore, MDCT detected prominent subprosthetic
tissue in one patient and a large pseudoaneurysm and malig-
nant coronary anomaly in another patient. Above all, MDCT
Table 4 Morphological prosthetic valve assessment by multidetector-row computed tomography
Aortic PHV Mitral PHV
Mechanical N=25 Biological N=15 Mechanical N=8 Biological N=1
Pledgets visible, n (%) 17 (68 %) 12 (80 %) 6 (75 %) 1 (100 %)
Periaortic fat tissue induration 22 (88 %) 11 (73 %) n/a n/a
Leaflet thickening - - - -
Thrombus - - - -
Subprosthetic tissue - 1 (7 %) - -
Vegetations - - - -
Abscesses - - - -
Pseudoaneurysms 1 (4 %) 1 (7 %) - -
Valve dehiscence 1 (4 %) - - -
Valve angulation* 1 (4 %) 2 (13 %) - -
Abnormal pericardial effusion 1 (4 %) 2 (13 %) - -
Pericardial haeamatoma 2 (8 %) 1 (7 %) - -
n/a not applicable, PHV prosthetic heart valve
* To the left ventricular outflow tract axis
Fig. 5 Unexpected pathology requiring redo valve surgery. Fifty-one-
year old female patient after valve replacement surgery with the
mechanical St. Jude 23-mm prosthesis in aortic position. Multidetector-
row computed tomography imaging (a-c) showed extended
pseudoaneurysm formation (arrowheads) and valve dehiscence
eventually requiring redo surgery. Transthoracic echocardiography
detected only a trace of periprosthetic regurgitation, stated as clinically
not relevant
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detected severe valve dehiscence requiring redo surgery while
TTE only showed a trace of insignificant periprosthetic regur-
gitation. Thus, MDCT showed incremental value over echo-
cardiography in the assessment of anatomical structures near
the prosthesis and in the detection of related pathology such as
pseudoaneurysms. Recently, we demonstrated the feasibility
of MDCT for non-invasive coronary artery and bypass graft
assessment in PHV dysfunction patients [20].
The incidental (pathological) findings in this study may
need to be confirmed in larger series in order to assess their
long-term significance and to clarify the role of MDCT as a
screening modality. Because of the limitations of radiation
exposure, screening with MDCT may only be possible with
a certain amount of clinical suspicion. On the other hand, the
utilization of dose reduction strategies such as iterative image
reconstruction algorithms allows a far more widespread use of
MDCT.We did not incorporate these techniques in the current
study. Prospectively ECG-triggered MDCT acquisitions may
also save radiation exposure, but they do not provide dynamic
information on leaflet excursions. As shown in this study, the
optimal systolic and diastolic phases for PHVassessment dif-
fer substantially among patients. Hence, selecting the best
phase in advance as required with prospectively triggered im-
aging can be very challenging.
A strength of this study is the prospective cohort. No se-
lection was made based on clinical signs. Thus, a random
sample of normal patients shortly after successful valve re-
placement surgery is presented. All patients underwent TTE
and MDCT imaging in the same hospital centre using the
same devices and software for all patients. Furthermore,
MDCT and TTE were performed on the same day in 98 %
of patients, thereby virtually excluding differences in results
due to time effect and/or left ventricular filling conditions.
A limitation of the current study is that we could not assess
all currently available prosthetic valves. However, based on
available in vitro and in vivo MDCT studies we do not expect
significant differences with other contemporary valves [14].
Furthermore, patients with an impaired renal function were
excluded to reduce the risk of contrast-induced nephropathy.
For logistic purposes, the renal function was assessed early
after cardiothoracic surgery (before discharge). It is probable
that at 6 weeks after implantation renal function has recovered
and contrast-enhanced imaging can be performed in more pa-
tients. No beta blockers were administered before MDCT ac-
quisition, which may have affected image quality.
Conclusion
Six weeks after valve replacement surgery, MDCT allowed
evaluation of relevant anatomical regions in all PHVs in both
aortic and mitral position despite mild to moderate artefacts,
and presented baseline findings such as tilted aortic PHV
positions and prominent pericardial haematoma. A major ad-
ditional finding was induration of the periaortic fat tissue pres-
ent in 83 % of patients after uncomplicated aortic valve re-
placement. The use of MDCT as a complementary imaging
tool for follow-up in postoperative patients is feasible, and
revealed three cases of clinically relevant pathology that were
not detected by TTE imaging. Further studies are needed to
assess whether early abnormalities with MDCT in seemingly
normally functioning valves are as frequent as in this series.
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